Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Big volume today
View:
Post by JoeyBoston on Feb 10, 2021 12:45pm

Big volume today

J&J just said people will have to get vaccines for the next several years. Throw in the number of strains coming up, & you realize the importance of antibody testing. IF we get a Candian anitibody test approval & a Biogen aducanumab approval, we can be seeing $1+ stock price very soon.
Comment by BottomBroker on Feb 10, 2021 2:20pm
Everytime we get a small bump, the next stop is $1. Ha. My guess is we won't see that anytime soon, if ever. I hope we do, but I'm not holding my breath. 
Comment by Annayya on Feb 10, 2021 3:54pm
3 million shares traded so far today. It's the highest volume since November 2020. This stock went over 30 cents back in June 2020 with over 16 million volume. So a combination of covid test health Canada approval and aducanumab approval for Biogen and volume of over 50 million may push the SP to $1, although only temporarily. To sustain a consistent price above $1 we need to find a partner ...more  
Comment by M101 on Feb 10, 2021 4:01pm
Yeah, the covid test.  We are so lucky the world is in such deep doodoo.  Thank you neoliberalism!  And thank you Jesus that evolution is doing what it does with viruses. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities